Featured series 
Tag: Novartis
-
Science & Tech
Novel cancer treatment gets major boost
The Wyss Institute and Harvard John A. Paulson School of Engineering and Applied Sciences announced Novartis will have access to commercially develop their therapeutic, biomaterial-based cancer vaccine technology.
-
Health
How Zika infects the growing brain
Studies have suggested that the Zika virus enters neural progenitor cells by grabbing onto a specific protein called AXL on the cell surface. Now, scientists at the Harvard Stem Cell Institute and Novartis have shown that this is not the only route of infection. The scientists demonstrated that Zika infected neural progenitor cells even when…
-
Health
The knotty problem of bringing regenerative medicine to market
Leaders from the scientific and business world gathered at Harvard Business School on Oct. 6 to examine regenerative medicine’s scientific and commercial promise.
-
Health
What’s behind aggressive breast cancer
Harvard scientists at Dana-Farber Cancer Institute have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors, a typically aggressive cancer that is highly resistant to current therapies.
